Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

501. The Pillar Procedure: for the treatment of obstructive sleep apnoea and snoring

with suspected sleep apnea', Am J Respir Crit Care Med, 169 (6), 668- 672. Friedman, M., Vidyasagar, R. et al (2006). 'Patient selection and efficacy of pillar implant technique for treatment of snoring and obstructive sleep apnea/hypopnea syndrome', Otolaryngol Head Neck Surg, 134 (2), 187-196. The Pillar ® palatal implant system for the treatment of obstructive sleep apnoea 47Gould, D., Kelly, D. et al (2001). 'Examining the validity of pressure ulcer risk assessment scales: developing and using (...) 19th June 2006]. Stradling, J. R. & Davies, R. J. (2004). 'Sleep. 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history', Thorax, 59 (1), 73-78. Strohl, K. P. & Redline, S. (1996). 'Recognition of obstructive sleep apnea', Am J Respir Crit Care Med, 154 (2 Pt 1), 279-289. Sundaram, S., Bridgman, S. A. et al (2005). 'Surgery for obstructive sleep apnoea.' The Cochrane Database of Systematic Reviews: Reviews 2005 Issue 4 John Wiley & Sons, Ltd Chichester, UK

2006 Australia and New Zealand Horizon Scanning Network

502. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age

Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

503. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep Full Text available with Trip Pro

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep Vignatelli L, Billiard M, Clarenbach P, Garcia-Borreguero D, Kaynak D, Liesiene V, Trenkwalder C, Montagna P CRD summary The authors concluded that level A recommendations support the use (...) of cabergoline, gabapentin, pergolide, ropinirole, and short-term levodopa and transdermal rotigotine for primary restless leg syndrome. The evidence appears to support the authors’ conclusions, but the poor reporting of review methods makes it difficult to comment on the reliability of these conclusions. Authors' objectives To evaluate the effectiveness of treatments for restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) in sleep. Searching MEDLINE, EMBASE, CINAHL and the Cochrane

2006 DARE.

504. Outpatient BiPAP (bi-level positive airway pressure) in obstructive sleep apnea

Outpatient BiPAP (bi-level positive airway pressure) in obstructive sleep apnea Outpatient BiPAP (bi-level positive airway pressure) in obstructive sleep apnea Outpatient BiPAP (bi-level positive airway pressure) in obstructive sleep apnea Pichon Riviere A, Augustovski F, Alcaraz A, Bardach A, Ferrante D, Garcia Marti S, Lopez A, Glujovsky D, Regueiro A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation Pichon Riviere A, Augustovski F, Alcaraz A, Bardach A, Ferrante D, Garcia Marti S, Lopez A, Glujovsky D, Regueiro A. Outpatient BiPAP (bi-level positive airway pressure) in obstructive sleep apnea. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No.64. 2006 Authors' objectives This report is intended to assess the usefulness of outpatient BiPAP in patients with obstructive sleep apnea. Authors

2006 Health Technology Assessment (HTA) Database.

505. Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis

bariatric surgery. That said, in view of the identification of OSA in the past 30 years and that the understanding of its causes, consequences and optimal treatment are still under evolution, and further research is warranted to identify which patients should be screened for OSA. Final publication URL Additional data URL Indexing Status Subject indexing assigned by CRD MeSH Obesity /therapy /surgery /prevention & Polysomnography; Sleep Apnea, Obstructive /therapy /diagnosis; Sleep Wake Disorders (...) with obstructive sleep apnea: an evidence-based analysis. Toronto: Medical Advisory Secretariat (MAS). Volume 6(13). 2006 Authors' objectives This report evaluates the clinical utility and cost-effectiveness of polysomnography (PSG) in the diagnosis and management of sleep disorders. Authors' conclusions Considerations for Policy Development Obesity, rather than obstructive sleep apnea (OSA), leads to cardiovascular consequences. Treating and preventing obesity would substantially reduce the economic burden

2006 Health Technology Assessment (HTA) Database.

506. The effectiveness of tonsillectomy and adenoidectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis

The effectiveness of tonsillectomy and adenoidectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

507. Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome

Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome Deutsch P A, Simmons M S, Wallace J M Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study compared three strategies for diagnosing and treating obstructive sleep apnoea syndrome (OSAS). Strategy 1 was full-night polysomnography (PSG). This consisted of an overnight in-laboratory PSG followed by continuous positive airway pressure (CPAP) titration during

2006 NHS Economic Evaluation Database.

508. Review: behaviour therapy is effective for insomnia

Review: behaviour therapy is effective for insomnia Review: behaviour therapy is effective for insomnia | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: behaviour therapy is effective for insomnia Article Text Treatment Review: behaviour therapy is effective for insomnia Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance

2006 Evidence-Based Nursing

509. Response to a 2 week continuous positive airway pressure trial accurately identified patients with obstructive sleep apnoea syndrome

Response to a 2 week continuous positive airway pressure trial accurately identified patients with obstructive sleep apnoea syndrome Response to a 2 week continuous positive airway pressure trial accurately identified patients with obstructive sleep apnoea syndrome | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please (...) apnoea syndrome Article Text Diagnosis Response to a 2 week continuous positive airway pressure trial accurately identified patients with obstructive sleep apnoea syndrome Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. Copyright information

2006 Evidence-Based Medicine

510. Review: behaviour therapy is effective for insomnia

Review: behaviour therapy is effective for insomnia Review: behaviour therapy is effective for insomnia | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password (...) ? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: behaviour therapy is effective for insomnia Article Text Therapeutics Review: behaviour therapy is effective for insomnia Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you

2006 Evidence-Based Medicine

511. Obstructive sleep apnea as a risk factor for stroke and death. Full Text available with Trip Pro

) were verified. The diagnosis of the obstructive sleep apnea syndrome was based on an apnea-hypopnea index of 5 or higher (five or more events per hour); patients with an apnea-hypopnea index of less than 5 served as the comparison group. Proportional-hazards analysis was used to determine the independent effect of the obstructive sleep apnea syndrome on the composite outcome of stroke or death from any cause.Among 1022 enrolled patients, 697 (68 percent) had the obstructive sleep apnea syndrome (...) . At baseline, the mean apnea-hypopnea index in the patients with the syndrome was 35, as compared with a mean apnea-hypopnea index of 2 in the comparison group. In an unadjusted analysis, the obstructive sleep apnea syndrome was associated with stroke or death from any cause (hazard ratio, 2.24; 95 percent confidence interval, 1.30 to 3.86; P=0.004). After adjustment for age, sex, race, smoking status, alcohol-consumption status, body-mass index, and the presence or absence of diabetes mellitus

2005 NEJM

512. Surgery for obstructive sleep apnoea. (Abstract)

Surgery for obstructive sleep apnoea. Obstructive sleep apnoea/hypopnoea syndrome(OSAHS) is the periodic reduction or cessation of airflow during sleep. The syndrome is associated with loud snoring, disrupted sleep and observed apnoeas. Surgery for obstructive sleep apnoea/hypopnoea syndrome aims to alleviate symptoms of daytime sleepiness, improve quality of life, and reduce the signs of sleep apnoea recorded by polysomnography.The objective of this review was to assess the effects of any type (...) of surgery for the treatment of the symptoms of obstructive sleep apnoea/hypopnoea syndrome in adults.We searched the Cochrane Airways Group Specialised Register and reference lists of articles. We contacted experts in the field, research dissemination bodies and other Cochrane Review Groups. Searches were current as of July 2005.Randomised trials comparing any surgical intervention for obstructive sleep apnoea/hypopnoea syndrome with other surgical or non-surgical interventions or no intervention.Two

2005 Cochrane

513. CBT added to tapering helped patients with chronic insomnia discontinue benzodiazepine use Full Text available with Trip Pro

), impaired daytime functioning or mood disturbances, and benzodiazepine use (on >50% of nights) for ⩾3 months. Exclusion criteria included medical or psychiatric disorders known to cause insomnia, sleep apnoea, periodic limb movements during sleep and other psychiatric disorders or cognitive impairment. Intervention: 10 weeks of CT (n = 27), CBT (n = 24), or SMT (n = 25). SMT in both CT and SMT alone groups aimed for dosage reductions of 25% at 2 week intervals until the lowest available dose of the BDP (...) * CONCLUSION In older patients with chronic insomnia, cognitive behavioural therapy plus tapering was superior to either therapy alone for discontinuing benzodiazepines at 10 weeks but not in the longer term (3–12 months). Commentary The study by Morin et al provides 2 lessons. Firstly, 50% of eligible participants were excluded (many because of comorbid medical [mostly sleep apnoea] or psychiatric disorders), emphasising the need to screen for and treat these disorders before stopping BDPs. Secondly

2005 Evidence-Based Medicine

514. Practice parameters for the nonpharmacologic treatment of chronic primary insomnia in the elderly.

Practice parameters for the nonpharmacologic treatment of chronic primary insomnia in the elderly. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures

2005 University of Texas at Austin School of Nursing, Family Nurse Practitioner Program

515. Cognitive behavioural therapy improved benzodiazepine discontinuation in chronic insomnia Full Text available with Trip Pro

McMillan , RN, PhD Statistics from Altmetric.com Baillargeon L, Landreville P, Verreault R, et al . Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 2003 ; 169 : 1015 –20. Q In older patients with chronic insomnia who have been taking a benzodiazepine nightly for ⩾3 months, is cognitive behavioural therapy plus tapering (CBTT) more effective than tapering alone (TA) for inducing (...) benzodiazepine discontinuation? METHODS Design: randomised controlled trial. Allocation: not concealed. Blinding: unblinded. Follow up period: 12 months. Setting: a university hospital in Sainte-Foy, Québec, Canada. Patients: 65 patients ⩾50 years of age (mean age 67 y, 58% women) with chronic insomnia (⩾6 months); impaired daytime functioning or mood disturbances; nightly benzodiazepine use for ⩾3 months; and inability to refrain from taking a hypnotic for fear of poor sleep or reported <80% sleep

2005 Evidence-Based Nursing

516. Day-night pattern of sudden death in obstructive sleep apnea. (Abstract)

a significantly higher apnea-hypopnea index than those with sudden death from cardiac causes during other intervals, and the apnea-hypopnea index correlated directly with the relative risk of sudden death from cardiac causes from midnight to 6 a.m. For people with obstructive sleep apnea, the relative risk of sudden death from cardiac causes from midnight to 6 a.m. was 2.57 (95 percent confidence interval, 1.87 to 3.52). The analysis of usual sleep-wake cycles showed similar results.People with obstructive (...) undergone polysomnography and had died suddenly from cardiac causes between July 1987 and July 2003. For four intervals of the day, we compared the rates of sudden death from cardiac causes among people with obstructive sleep apnea and the following: the rates among people without obstructive sleep apnea, the rates in the general population, and the expectations according to chance. For each interval, we assessed the median apnea-hypopnea index and the relative risk of sudden death from cardiac causes

2005 NEJM

517. Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. (Abstract)

Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. The role of atrial overdrive pacing (AOP) in sleep apnea remains uncertain. We prospectively evaluated the effect of AOP after 24 hours and after one month in patients with the obstructive sleep apnea-hypopnea syndrome and compared it with the use of nasal continuous positive airway pressure (n-CPAP).We studied 16 patients with a moderate or severe case of the obstructive sleep apnea-hypopnea syndrome (baseline mean (...) positive airway pressure therapy is highly effective for the treatment of the obstructive sleep apnea-hypopnea syndrome, whereas AOP has no significant effect.Copyright 2005 Massachusetts Medical Society.

2005 NEJM Controlled trial quality: uncertain

518. Modafinil for excessive sleepiness associated with shift-work sleep disorder. Full Text available with Trip Pro

Modafinil for excessive sleepiness associated with shift-work sleep disorder. Patients with shift-work sleep disorder chronically have excessive sleepiness during night work and insomnia when attempting to sleep during the day. We evaluated the use of modafinil for treating sleepiness in patients with this disorder.In a three-month, double-blind trial, we randomly assigned 209 patients with shift-work sleep disorder to receive either 200 mg of modafinil or placebo before the start of each shift (...) had accidents or near accidents while commuting home (29 percent vs. 54 percent, respectively; P<0.001). Despite these benefits, patients treated with modafinil continued to have excessive sleepiness and impaired performance at night. Modafinil did not adversely affect daytime sleep as compared with placebo. Headache was the most common adverse event.Treatment with 200 mg of modafinil reduced the extreme sleepiness that we observed in patients with shift-work sleep disorder and resulted in a small

2005 NEJM Controlled trial quality: uncertain

519. Continuous positive airway pressure for central sleep apnea and heart failure. Full Text available with Trip Pro

fraction, 24.5+/-7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40+/-16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained.Three months after undergoing randomization, the CPAP group, as compared with the control group, had (...) Continuous positive airway pressure for central sleep apnea and heart failure. The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure.After medical therapy was optimized, 258 patients who had heart failure (mean age [+/-SD], 63+/-10 years; ejection

2005 NEJM Controlled trial quality: uncertain

520. A systematic review of the effectiveness of oral melatonin for adults (18 to 65 years) with delayed sleep phase syndrome and adults (18 to 65 years) with primary insomnia

to 65 years) with delayed sleep phase syndrome and adults (18 to 65 years) with primary insomnia. Current Psychiatry Reviews 2005; 1(1): 103-113 Indexing Status Subject indexing assigned by CRD MeSH Administration, Oral; Age Factors; Circadian Rhythm /drug effects; Melatonin /administration & Sleep /drug effects; Sleep Wake Disorders, Circadian Rhythm /complications /diagnosis /drug therapy; Time Factors; Treatment Outcome; Wakefulness /drug effects; dosage /therapeutic use AccessionNumber (...) A systematic review of the effectiveness of oral melatonin for adults (18 to 65 years) with delayed sleep phase syndrome and adults (18 to 65 years) with primary insomnia A systematic review of the effectiveness of oral melatonin for adults (18 to 65 years) with delayed sleep phase syndrome and adults (18 to 65 years) with primary insomnia A systematic review of the effectiveness of oral melatonin for adults (18 to 65 years) with delayed sleep phase syndrome and adults (18 to 65 years

2005 DARE.